164. Macmaster, F. P., & Kusumakar, V. (2004). Hippocampal volume in early onset depression. BMC Medicine, 2. doi:10.1186/1741-7015-2-2.
165. McCurley, J. L., Mills, P. J., Roesch, S. C. et al. (2015). Chronic stress, inflammation, and glucose regulation in U.S. Hispanics from the HCHS/SOL Sociocultural Ancillary Study. Psychophysiology, 52(8), 1071–1079. http://doi.org/10.1111/psyp.12430.
166. Aschbacher, K., Kornfeld, S., Picard, M. et al. (2014). Chronic stress increases vulnerability to diet-related abdominal fat, oxidative stress, and metabolic risk, Psychoneuroendocrinology, 46, 14–22. doi:10.1016/j.psyneuen.2014.04.003.
167. Castelli, W. P. (1986). The triglyceride issue: A view from Framingham. American Heart Journal, 112(2), 432–437.
168. Nielsen, S. E., Ahmed, I., & Cahill, L. (2014). Postlearning stress differentially affects memory for emotional gist and detail in naturally cycling women and women on hormonal contraceptives. Behavioral Neuroscience, 128(4), 482–493. doi:10.1037/a0036687.
169. Roney, J. R. (in preparation). Cortisol increases in response to sexual attraction.
170. Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011). A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(3), 676–692. doi:10.1016/j.pnpbp.2010.05.004; Zunszain, P. A., Anacker, C., Cattaneo, A. et al. (2011). Glucocorticoids, cytokines and brain abnormalities in depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(3), 722–729. doi:10.1016/j.pnpbp.2010.04.011.
171. Tsigos, C., & Chrousos, G. P. (2002). Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. Journal of Psychosomatic Research, 53(4), 865–871. doi:10.1016/S0022-3999(02)00429-4; Fries, E., Hesse, J., Hellhammer, J., & Hellhammer, D. H. (2005). A new view on hypocortisolism. Psychoneuroendocrinology, 30(10), 1010–1016. doi:10.1016/j.psyneuen.2005.04.006.
172. Hannibal, K. E., & Bishop, M. D. (2014). Chronic stress, cortisol dysfunction, and pain: A psychoneuroendocrine rationale for stress management in pain rehabilitation. Physical Therapy, 94(12), 1816–1825. doi:10.2522/ptj.20130597.
173. Tsigos, C., & Chrousos, G. P. (2002). Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. Journal of Psychosomatic Research, 53(4), 865–871. doi:10.1016/S0022-3999(02)00429-4; Fries, E., Hesse, J., Hellhammer, J., & Hellhammer, D. H. (2005). A new view on hypocortisolism. Psychoneuroendocrinology, 30(10), 1010–1016. doi:10.1016/j.psyneuen.2005.04.006.
174. Sørensen, C. J., Pedersen, O. B., Petersen, M. S. et al. (2014). Combined oral contraception and obesity are strong predictors of low-grade inflammation in healthy individuals: Results from the Danish Blood Donor Study (DBDS). PLOS One, 9(2). doi:10.1371/journal.pone.0088196.
175. Williams, W. V. (2017). Hormonal contraception and the development of autoimmunity: A review of the literature. Linacre Quarterly, 84(3), 275–295. doi:10.1080/00243639.2017.1360065.
176. Fairweather, D., Frisancho-Kiss, S., & Rose, N. R. (2008). Sex differences in autoimmune disease from a pathological perspective. American Journal of Pathology, 173(3), 600–609. http://doi.org/10.2353/ajpath.2008.071008.
Глава 8
177. Sanders, S. A., Graham, C. A., Bass, J. L., & Bancroft, J. (2001). A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception, 64(1), 51–58. doi:10.1016/s0010-7824(01)00218-9.
178. Gingnell, M., Engman, J., Frick, A. et al. (2013). Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill: A double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive. Psychoneuroendocrinology, 38(7), 1133–1144. doi:10.1016/j.psyneuen.2012.11.006; Sanders, S. A., Graham, C. A., Bass, J. L., & Bancroft, J. (2001). A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception, 64(1), 51-58. doi:10.1016/s0010-7824(01)00218-9; Rosenberg, M. J., & Waugh, M. S. (1998). Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons. American Journal of Obstetrics and Gynecology, 179(3), 577–582. doi:10.1016/s0002-9378(98)70047-x; Jarva, J. A., & Oinonen, K. A. (2007). Do oral contraceptives act as mood stabilizers? Evidence of positive affect stabilization. Archives of Women’s Mental Health, 10(5), 225–234. doi:10.1007/s00737-007-0197-5.
179. Thygesen, L. C., Daasnes, C., Thaulow, I., & Brønnum-Hansen, H. (2011). Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving. Scandinavian Journal of Public Health, 39(Suppl. 7), 12–16. doi:10.1177/1403494811399956.
180. Thygesen, L. C., Daasnes, C., Thaulow, I., & Brønnum-Hansen, H. (2011). Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving. Scandinavian Journal of Public Health, 39(Suppl. 7), 12–16. doi:10.1177/1403494811399956.
181. Skovlund, C. W., Mørch, L. S., Kessing, L. V., & Lidegaard, Ø. (2016). Association of hormonal contraception with depression. JAMA Psychiatry, 73(11), 1154–1162. doi:10.1001/jamapsychiatry.2016.2387.
182. Toffol, E., Heikinheimo, O., Koponen, P. et al. (2011). Hormonal contraception and mental health: Results of a population-based study. Human Reproduction, 26(11), 3085–3093. doi:10.1093/humrep/der269; Gingnell, M., Engman, J., Frick, A. et al. (2013). Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill: A double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive. Psychoneuroendocrinology, 38(7), 1133–1144. doi:10.1016/j.psyneuen.2012.11.006.
